Kathleen L. Hefferon
Scientific Tracks Abstracts: J Bioequiv Availab
Kayser completed his PhD at the University of Leeds in the UK, in the School of Chemistry in 2004. He then did two postdoctoral studies: first at the Max Planck Institute of Biochemistry in Germany and then at MIT studying protein folding and aggregation, particularly with monoclonal antibodies, and formulation development. Subsequently, he stayed at MIT as a senior scientist working on vaccine formulation and method development as well as particle size analysis. He has published more than 15 papers on the subject in reputed journals and serves as an associate editor of Open Journal of Biophysics.